Home > Healthcare > Medical Devices > Diagnostic Devices > Cancer Diagnostics Market
Cancer Diagnostics Market Share
- Report ID: GMI2406
- Published Date: Jan 2023
- Report Format: PDF
Cancer Diagnostics Market Share
Some of the leading companies in the global cancer diagnostics market include
- Agilent Technologies Inc
- Abbott Laboratories
- Becton
- Dickinson and Company
- AB Sciex Pte. Ltd
- Biocare Medical LLC
- BioMerieux SA
- Biocartis
- Bio-Rad Laboratories
- GE Healthcare
- Janssen Diagnostics LLC (Johnson & Johnson)
- Cancer Genetics Inc
- Hologic Inc
- Leica Biosystem Nussloch GmbH (Danaher Corporation)
- Qiagen N.V
- F-Hoffmann-La Roche Ltd
- Myriad Genetics, Inc
- Siemens Healthineers
- Thermo Fischer Scientific
- Sysmex Corporation
These firms are developing advanced products with superior performance capabilities for better consumer traction.
Frequently Asked Questions (FAQ) :
Global market for cancer diagnostics was worth more than USD 136 billion in 2022 and is projected to exhibit over 9% CAGR from 2023-2032.
Non-Hodgkin lymphoma (NHL) is estimated to reach over USD 18.5 billion by 2032 due to increasing prevalence in the aging population.
Europe cancer diagnostics market size is slated to surpass USD 93.5 billion by 2032 owing to the presence of growing healthcare expenditure and supportive initiatives.
Abbott Laboratories, BioMerieux SA, Biocartis, Hologic Inc, Qiagen N.V, Myriad Genetics, Inc, and Sysmex Corporation are some key participants in the market.
Cancer Diagnostics Market Scope
×
Get a free sample of
Cancer Diagnostics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below